
NYSE:ELAN
This summary was created by AI, based on 1 opinions in the last 12 months.
Elanco Animal Health has been experiencing a notable turnaround that has caught the attention of various experts and analysts. The company's shift in strategy and operations has led to improved performance metrics, fostering a sense of optimism in its future potential. Many are impressed by the decisive actions taken by the management, which appear to be yielding positive results. Overall, the prevailing sentiment suggests that Elanco is on a promising path, showcasing resilience and adaptability in a competitive landscape. This momentum has garnered a favorable outlook from those closely monitoring its developments.
Spun off from Eli Lilly in 2018. Reported a mixed report today, including their pet business missing as guidance for the current quarter fell short. They will sell its Aqua business to Merck Animal Health, announced restructuring/job cuts and will increase cash flow conversions four times this year, which is a priority. This gives him some hope in the name.
Elanco Animal Health is a American stock, trading under the symbol ELAN (previously ELAN-N on Stockchase) on the New York Stock Exchange (ELAN). It is usually referred to as NYSE:ELAN or ELAN
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on ELAN (previously ELAN-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Elanco Animal Health.
Elanco Animal Health was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Elanco Animal Health.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Elanco Animal Health.
Elanco Animal Health is covered by Stockchase experts and is worth watching.
On 2026-07-24, Elanco Animal Health (ELAN) stock closed at a price of $24.92.
Is impressed with their turnaround.